Carbamazepine
- Product NDC
- 70518-0181
- 11-digit product format
- 705180181
- Labeler code
- 70518
- Product ID
- 70518-0181_e6fe15ff-edb3-ee37-e053-2a95a90a8135
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbamazepine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA078115
- Marketing category
- ANDA
- Marketing start
- 2017-01-27
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-0181-0 | 70518018100 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-0181-0) | | 2017-01-27 | 0000-00-00 | No | No | Current |
| 70518-0181-1 | 70518018101 | 100 POUCH in 1 BOX (70518-0181-1) > 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-0181-2) | 100 pouch | 2019-10-26 | 0000-00-00 | No | No | Current |